category:risks A new risk? Macular Degeneration We explore the new GLP1 risk factor for macular degeneration (nAMD) that has been reported in a study published to JAMA.
category:side-effects Ozempic is not likely to directly enlarge the male appendage. A critical look at the popular "ozempic penis" claims and look at the sources, along with possible reasons and related research.
category:news A new risk: Kidney Cancer New study suggests link between GLP1 Receptor Agonists (Ozempic, Mounjaro, etc) and kidney cancer.
category:side-effects Pancreatitis and Gallstones after massive weight loss We look into pancreatitis and gallstones issues that caused one death and more hospitalizations, caused at least in part by GLP1s
category:side-effects Anxiety and suicidal thoughts after stopping GLP1s? Reports of anxiety and suicidal reports have been reported for people after *stopping* use of GLP1s. We dig in, and weight the FDA's comments.
category:side-effects Semaglutide's link to blinding disease (NAION) We explore the link between blinding disease/vision loss and Semaglutide, as reported by medical research.
category:side-effects Thyroid issues with GLP1? Do GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, Zepbound, and others) cause thyroid issues?
includes:study Are GLP1 side effects all the same? Do some GLP1s have less negative side effects? They work the same, but can affect you differently -- let's look at the research.
